Paul Daniel Regan

Affiliations

  • Director at Keryx Biopharmaceuticals Inc (KERX), 2018-12-13
  • Chief Commercial Officer at Intercept Pharmaceuticals Inc (ICPT), 2015-02-04
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ICPT $208.08 200 $41,616.00 1,264 2015-01-30 Filing
ICPT $205.87 800 $164,698.48 1,464 2015-01-30 Filing
ICPT $202.49 793 $160,577.42 2,264 2015-01-30 Filing
ICPT $201.50 1,207 $243,212.67 3,057 2015-01-30 Filing
ICPT $200.07 6,847 $1,369,858.75 4,264 2015-01-30 Filing